A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Seroprevalence of rubella hemagglutination inhibition and rubella-specific IgM antibodies and the significance of rubella-specific IgM antibody measurement in pregnant Japanese women: A retrospective study
[post]
2022
unpublished
Background Cases of congenital rubella syndrome are reported annually in Japan. Rubella-specific IgM antibody titers can show false positivity or remain positive for a long period. Furthermore, the seroprevalence of rubella hemagglutination inhibition (HI) and IgM antibodies is unknown, and the relevance of measuring rubella-specific IgM antibodies in asymptomatic individuals is unclear. Hence, this study aimed to assess the validity of rubella-specific IgM antibody titers as a diagnostic
doi:10.21203/rs.3.rs-2339538/v1
fatcat:j3mu3le2sffu5jpqppaor6ptxm